Management
These innovative substances act as true bone graft substitutes, thereby allowing the surgeon to avoid the use of autogenous bone grafts and their associated donor site morbidity [PMID:11823929].
Craniomaxillofacial surgeons must therefore become comfortable with numerous biomaterials to best tailor the treatment for each patient individually [PMID:11823929].
Prognosis & Follow-up
These materials aim to heal faster by induction, incorporate with surrounding tissues, and be remodeled to resemble native bone, potentially enhancing long-term outcomes [PMID:11823929].
References
1 Costantino PD, Hiltzik D, Govindaraj S, Moche J. Bone healing and bone substitutes. Facial plastic surgery : FPS 2002. link
1 papers cited of 3 indexed.